Cost-Effectiveness Assessment of Herpes Zoster Vaccination in Germany

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.2307
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pin56 - Cost-Effectiveness of Varicella and Herpes Zoster Vaccination in the Swedish Population

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PIN63 Vaccination Against Herpes Zoster and Post-Herpetic Neuralgia in France: A Cost-Effectiveness Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Pin67 - Cost-Effectiveness of Quadrivalent Influenza Vaccination in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Distribution of Health Effects and Cost-Effectiveness of Varicella Vaccination Are Shaped by the Impact on Herpes Zoster

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Herpes Zoster Provoked by Smallpox Vaccination

BMJ
1950English

Better Effectiveness of Herpes Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus With Ocular Involvement

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Epidemiology and Costs of Varicella and Herpes Zoster in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

The Impact of Demographic Changes, Exogenous Boosting and New Vaccination Policies on Varicella and Herpes Zoster in Italy: A Modelling and Cost-Effectiveness Study

BMC Medicine
Medicine
2018English

The Epidemiology of Varicella and Herpes Zoster in the Netherlands: Implications for Varicella Zoster Virus Vaccination

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy